Protalix BioTherapeutics, Inc. (PLX) › Gross ProfitProtalix BioTherapeutics, Inc. (PLX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2009: -$3.19M2010: $6.86M2011: $1.44M2012: $26.28M2013: $02014: $2.89M2015: $3.63M2016: $801.0K2017: $4.01M$4.01M2009Gross Profit (USD)2017Fiscal YearGross ProfitChange YoY2017$4.01M+400.7%2016$801.0K-78.0%2015$3.63M+25.6%2014$2.89M—2013$0-100.0%2012$26.28M+1721.2%2011$1.44M-79.0%2010$6.86M+315.3%2009-$3.19M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share